Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
Similar Posts
Precision gene editing clarifies role of a master gene in human embryo
Scientists at the University of Cambridge have used the base editing technique to modify a single gene in human embryos for the first time. The study shows the crucial role…
Step length as a marker for cognitive decline in dogs
Shorter forelimb stride length is associated with cognitive decline in older dogs. This is shown by a study from North Carolina State University. The results complement the…
New findings on liver regeneration after operations
Researchers at Michigan State University have refuted a long-standing scientific consensus on the role of the protein plasminogen in liver regeneration after operations. Lower plasminogen levels promoted in...
